Variation of heat flow with wall temperature. by Lei Bai (631944)

Subjects:

Fractal dimension evolution of oil droplet flame under different spray hole diameter. by Lei Bai (631944)

Subjects:

Evolution of flame fractal dimension of oil droplets with different volumes. by Lei Bai (631944)

Subjects:

Crude and adjusted times and hazard ratios for child mortality. by Samuel Sendagala (21417164)

Subjects:

Changes in the physiological indexes of two oat varieties under drought stress and normal water supply treatments. by Caijin Chen (3107787)

Subjects:

Baseline characteristics of mother–infant pairs by child mortality status (N = 11,519). by Samuel Sendagala (21417164)

Subjects:

WGCNA of the sample characteristics and proteins of the two oat varieties under drought stress. by Caijin Chen (3107787)

Subjects:

Changes in the growth of two oat varieties under drought stress and normal water supply treatments. by Caijin Chen (3107787)

Subjects:

Child mortality rate per 1,000 person-years during the 18-month follow-up period. by Samuel Sendagala (21417164)

Subjects:

Volcano map of DAPs. by Caijin Chen (3107787)

Subjects:

KEGG pathway enrichment bubble map of the top 20 DAPs. by Caijin Chen (3107787)

Subjects:

Normalized sample plots for each treatment for data quality control. by Caijin Chen (3107787)

Subjects:

Basic physical and chemical properties of the soils. by Caijin Chen (3107787)

Subjects:

Kaplan–Meier cumulative survival curve for infants exposed and not exposed to HIV. by Samuel Sendagala (21417164)

Subjects:

Mortality dataset used in analysis. by Samuel Sendagala (21417164)

Subjects:

Different responses of two oat varieties to drought stress. by Caijin Chen (3107787)

Subjects:

GO enrichment of DAPs, including BP, CC, and MF. by Caijin Chen (3107787)

Subjects:

Data Sheet 1_Analysis of pharmacotherapeutic approaches for multiple myeloma and correlated renal and pulmonary impairments: a retrospective real-world registry study in the Greate... by Ayman Alhejazi (21092054)

“…Background<p>Multiple myeloma (MM) is a plasma cell malignancy with significant unmet medical needs, particularly in the treatment of relapsed and refractory disease. …”

Study selection criteria. by Filip Stanicic (17808254)

“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”

PICOS criteria for the SLR. by Filip Stanicic (17808254)

“…Phase II/III trials consistently reported significantly greater CAPS improvement with MDMA-AT vs. placebo with therapy (PT) after two or three interventional sessions. …”